This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Dec;12(12):911.

doi: 10.1016/S1473-3099(12)70279-7.

Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa

Lutgarde Lynen, Katrien Fransen, Johan Van Griensven, Robert Colebunders

PMID: 23174380
DOI: 10.1016/S1473-3099(12)70279-7

Comment

Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa

Lutgarde Lynen et al. Lancet Infect Dis. 2012 Dec.

. 2012 Dec;12(12):911.

doi: 10.1016/S1473-3099(12)70279-7.

Authors

Lutgarde Lynen, Katrien Fransen, Johan Van Griensven, Robert Colebunders

PMID: 23174380
DOI: 10.1016/S1473-3099(12)70279-7

No abstract available

PubMed Disclaimer

Comment on

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.
Hamers RL, Schuurman R, Sigaloff KC, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Wit FW, van Vugt M, Stevens WS, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER) Investigators. Hamers RL, et al. Lancet Infect Dis. 2012 Apr;12(4):307-17. doi: 10.1016/S1473-3099(11)70255-9. Epub 2011 Oct 27. Lancet Infect Dis. 2012. PMID: 22036233 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information